U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849128) titled 'NeuroReAlign Therapy for Cognitive Rehabilitation in Patients with Stroke' on Feb. 20.
Brief Summary: The goal of this randomized controlled trial is to investigate the effects of NeuroReAlign Therapy on cognition in stroke survivors in the chronic stage (>6 months). The study will include male and female participants aged 18-70 years.
The main questions it aims to answer are:
Does NeuroReAlign Therapy improve cognition in stroke survivors compared to conventional physiotherapy? Researchers will compare NeuroReAlign Therapy to conventional cognitive therapy to determine its effects on cognition.
Participants will:
Undergo NeuroR...